Cellares has just closed a major $255 million third-round financing that will be used to complete a highly automated facility in New Jersey for the production of cell ther
Special purpose acquisition company (SPAC) eureKING has agreed a deal to buy SCTbio as part of a plan to build a contract manufacturing company specialising in biologic th
The severe damage caused by a tornado to one of the largest facilities making sterile injectables in the US has raised fears it could exacerbate shortages of some medicine